What's on this Page
What is Respiratory Syncytial Virus Immune Globulin RSV IGIV
RespiGam(TM) (RSV IGIV), formerly known as Respivir(TM), is a polyclonal human hyperimmune globulin.
It is used to prevent lower respiratory syncytial virus (RSV) disease in high-risk children under 24 months of age with bronchopulmonary dysplasia (BPD) or chronic lung disease, or in infants with a history of premature birth.
Brand Name
RespiGam
Indications
- respiratory syncytial virus (RSV) infection prophylaxis
For respiratory syncytial virus (RSV) infection prophylaxis in pediatric patients at high risk of RSV disease
Side Effects
- abdominal pain
- anaphylactoid reactions
- angioedema
- anxiety
- arthralgia
- aseptic meningitis
- cough
- cyanosis
- diarrhea
- dizziness
- drowsiness
- dyspnea
- edema
- fever
- flushing
- hypertension
- infection
- myalgia
- nausea
- pallor
- palpitations
- pruritus
- pulmonary edema
- rhinorrhea
- tachypnea
- vomiting
- wheezing
Monitoring Parameters
- laboratory monitoring not necessary
Contraindications
- acquired immunodeficiency syndrome (AIDS)
- albumin hypersensitivity
- breast-feeding
- congenital heart disease
- geriatric
- hepatic disease
- hypervolemia
- IgA deficiency
- immunosuppression
- pregnancy
- renal disease
- renal impairment
Interactions
- Measles Virus; Mumps Virus; Rubella Virus; Varicella Virus Vaccine, Live
- Varicella-Zoster Virus Vaccine, Live
